Scarica l'app Stockscreener
3.84
0.00%
0.00
Dopo l'orario di chiusura:
3.84
Precedente Chiudi:
$3.84
Aprire:
$3.78
Volume 24 ore:
602.46K
Relative Volume:
2.32
Capitalizzazione di mercato:
$143.91M
Reddito:
$147.12M
Utile/perdita netta:
$-33.88M
Rapporto P/E:
-3.6148
EPS:
-1.0623
Flusso di cassa netto:
$2.63M
1 W Prestazione:
-0.78%
1M Prestazione:
-46.89%
6M Prestazione:
-45.61%
1 anno Prestazione:
-46.67%
Intervallo 1D:
$3.68
$3.87
Intervallo di 1 settimana:
$3.625
$3.90
Portata 52W:
$3.625
$8.9799
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Nome
Lifecore Biomedical Inc
Settore
Telefono
(952) 368-4300
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
3.84 | 143.91M | 147.12M | -33.88M | 2.63M | -1.0623 |
TAK
Takeda Pharmaceutical Co Adr
|
18.74 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
117.94 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.93 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.08 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
564.81 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-17 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2025-09-04 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-05-21 | Iniziato | William Blair | Outperform |
| 2024-09-05 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Mostra tutto
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
LFCR.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
LFCR PE Ratio & Valuation, Is LFCR Overvalued - Intellectia AI
When Should You Buy Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - Yahoo Finance
LFCR Should I Buy - Intellectia AI
Landec Corp. (US5147661046.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Transition period Earnings Call Transcript - MarketBeat
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical (LFCR) price target decreased by 25.71% to 6.63 - MSN
Momentum Shift: Can Lifecore Biomedical Inc continue delivering strong returns2026 Trade Ideas & Intraday High Probability Alerts - baoquankhu1.vn
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Buybacks Report: Is Lifecore Biomedical Inc a top pick in the sectorNew Guidance & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Claim your share of the $3.75M Lifecore Biomedical securities class action settlement - Claim Depot
Lifecore Biomedical Earnings Call Signals Profitable Shift - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Lifecore signs two manufacturing deals with existing customer By Investing.com - Investing.com South Africa
Lifecore Biomedical (LFCR) to Release Earnings on Thursday - MarketBeat
Lifecore Biomedical, Inc. Common Stock (LFCR) Stock Price Today & Analysis - Gotrade
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Lifecore Biomedical Inks Two New Agreements with Existing US Customer - Contract Pharma
Lifecore signs two manufacturing deals with existing customer - Investing.com
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer - The Manila Times
LFCR: Barrington Research Maintains Outperform Rating with $5.50 Price Target | LFCR Stock News - GuruFocus
Lifecore Biomedical (NASDAQ:LFCR) Earns Outperform Rating from Barrington Research - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - accessnewswire.com
2026-03-24 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect | NDAQ:LFCR | Press Release - Stockhouse
Lifecore Biomedical signs third site transfer deal in five months By Investing.com - Investing.com Australia
Lifecore Biomedical Signs Commercial Manufacturing Services Agreement with Medical Aesthetics Company - MarketScreener
Lifecore Biomedical signs third site transfer deal in five months - Investing.com
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company - globenewswire.com
Published on: 2026-03-23 12:54:24 - baoquankhu1.vn
Lifecore stock sinks as delayed launches push growth further out - MSN
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation | NDAQ:LFCR | Press Release - Stockhouse
Aug Summary: Is Lifecore Biomedical Inc a strong candidate for buy and holdEarnings Overview Summary & Weekly Stock Performance Updates - baoquankhu1.vn
Rally Mode: Is Lifecore Biomedical Inc a top pick in the sector2026 Analyst Calls & High Accuracy Investment Signals - baoquankhu1.vn
Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Structure Therapeutics, Inc. Sponsored ADR (GPCR) and Lifecore Biomedical (LFCR) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - ACCESS Newswire
Lifecore Biomedical at KeyBanc Forum: Strategic Transformation Insights By Investing.com - Investing.com Canada
Lifecore Biomedical at KeyBanc Forum: Strategic Transformation Insights - Investing.com
Lifecore Biomedical (NASDAQ:LFCR) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
Lifecore Biomedical (NASDAQ:LFCR) Upgraded to Outperform at Barrington Research - MarketBeat
Why Is Lifecore Stock Sinking Tuesday?Lifecore Biomedical (NASDAQ:LFCR) - Benzinga
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Craig-Hallum Sticks to Its Buy Rating for Lifecore Biomedical (LFCR) - The Globe and Mail
Green Dot Corporation Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewswire Inc.
Lifecore Biomedical (LFCR) Q4 Loss Narrows To US$2 Million Reinforcing Bullish Margin Narratives - simplywall.st
Lifecore Biomedical earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada
Lifecore Biomedical Shareholders Are Encouraged to Reach - GlobeNewswire
Lifecore Biomedical Targets 12% Revenue CAGR and 25%+ EBITDA Margin by 2029 with CDMO Growth Strategy - Minichart
Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):